Resources
Nanopharm Resources
As a leader in the field of developing and testing nasal and inhaled drug delivery products, Nanopharm is committed to advancing scientific knowledge in this specialized area. Our team of dedicated scientists conduct cutting-edge research, and we are excited to share our content with you. By sharing our scientific publications webinars and white papers, we aim to foster a spirit of collaboration, inspire new ideas, and contribute to the collective knowledge of the OINDP scientific community. We encourage you to explore our resources page but please visit this section at regular intervals as our team continues to share the latest scientific articles with you.
11 February 2025
Advancing Alternative Bioequivalence for OINDPs
Bioequivalence, Nanopharm, OINDPs
Filter Resources By
01 Jun 2023
bioequivalence, Nanopharm, OINDP, PBPK modelling, Pharmacokinetic, SmartTrack
01 Dec 2022
Drug Product, Generic, Inhalation, OINDP, Pharmaceutical regulatory
14 May 2022
Accelerate Development, drug delivery, Formulation Development, Nanopharm, OINDP, Respiratory, Risk Mitigation, SmartTrack
01 May 2022
bioequivalence, Drug Development, Drug Solubility, In Vitro, In Vivo, Nanopharm, OINDP, Pharmacokinetics
14 Apr 2022
Biologics, drug delivery, Drug Development, Nanopharm, Nasal, SARS-CoV-2
09 Dec 2021
Biologics Characterization, cGMP, Drug Development, Nanopharm, OINDP, Particle Engineering
09 Dec 2021
Dry powder inhaler, Fluticasone Propionate, Inhalation
03 Nov 2021
Aerodynamic, Antigen, Dry Powder, GLA, Human Papillomavirus, Inhalation, Nanopharm, Performance, Vaccine
